Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Provisions: 2020-2025

Historic Tax Provisions for Keros Therapeutics (KROS) over the last 2 years, with Sep 2025 value amounting to -$1.4 million.

  • Keros Therapeutics' Tax Provisions was N/A to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $300,000 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Keros Therapeutics' Tax Provisions stood at -$1.4 million, which was up 35.91% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Keros Therapeutics' Tax Provisions ranged from a high of $10.0 million in Q1 2025 and a low of -$2.2 million during Q2 2025.
  • Moreover, its 2-year median value for Tax Provisions was -$562,000 (2024), whereas its average is $1.7 million.
  • Data for Keros Therapeutics' Tax Provisions shows a peak YoY spiked of 129.07% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Keros Therapeutics' Tax Provisions stood at $2.0 million in 2021, then followed by $300,000 in 2024, then followed by -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$2.2 million for Q2 2025, and $10.0 million during Q1 2025.